PL2882443T3 - Wyciągi roślinne wpływające na poprawę zdrowia poznawczego i funkcji poznawczej - Google Patents

Wyciągi roślinne wpływające na poprawę zdrowia poznawczego i funkcji poznawczej

Info

Publication number
PL2882443T3
PL2882443T3 PL13828399T PL13828399T PL2882443T3 PL 2882443 T3 PL2882443 T3 PL 2882443T3 PL 13828399 T PL13828399 T PL 13828399T PL 13828399 T PL13828399 T PL 13828399T PL 2882443 T3 PL2882443 T3 PL 2882443T3
Authority
PL
Poland
Prior art keywords
cognitive
plant extracts
health
improve
function
Prior art date
Application number
PL13828399T
Other languages
English (en)
Inventor
Michael Ceddia
Kelli HERRLINGER
Brandon LEWIS
Harry FENG
Original Assignee
Kemin Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries, Inc. filed Critical Kemin Industries, Inc.
Publication of PL2882443T3 publication Critical patent/PL2882443T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13828399T 2012-08-09 2013-08-09 Wyciągi roślinne wpływające na poprawę zdrowia poznawczego i funkcji poznawczej PL2882443T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
EP13828399.9A EP2882443B1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function
PCT/US2013/054274 WO2014026081A1 (en) 2012-08-09 2013-08-09 Plant extracts for improving cognitive health and function

Publications (1)

Publication Number Publication Date
PL2882443T3 true PL2882443T3 (pl) 2019-06-28

Family

ID=50066333

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13828399T PL2882443T3 (pl) 2012-08-09 2013-08-09 Wyciągi roślinne wpływające na poprawę zdrowia poznawczego i funkcji poznawczej

Country Status (11)

Country Link
US (2) US20140044813A1 (pl)
EP (1) EP2882443B1 (pl)
JP (4) JP2015524484A (pl)
KR (1) KR101947352B1 (pl)
CN (2) CN104684562A (pl)
AU (1) AU2013299491B2 (pl)
BR (1) BR112015002739A2 (pl)
CA (1) CA2880708C (pl)
ES (1) ES2715005T3 (pl)
PL (1) PL2882443T3 (pl)
WO (1) WO2014026081A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
AU2015210849B2 (en) * 2014-01-30 2018-11-22 Kemin Industries, Inc. Plant extracts for improving cognitive function
AU2015317990B2 (en) * 2014-09-15 2020-04-30 Kemin Industries, Inc. Plant extracts for improving cognitive function
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
EP3538085B1 (en) * 2016-11-11 2023-07-12 Kemin Industries, Inc. Use of a spearmint extract for improving the rate of neurogenesis
CN106727915B (zh) * 2017-01-18 2020-03-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
SG11202003879RA (en) * 2017-10-30 2020-05-28 Neuropore Therapies Inc Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用
JP7330630B2 (ja) * 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤
WO2024091653A1 (en) * 2022-10-27 2024-05-02 Kemin Industries, Inc. Use of a spearmint extract for retina neurotrophism

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1219509C (zh) * 1998-05-16 2005-09-21 财团法人牧岩生命工学研究所 迷迭香酸及其衍生物用于制备免疫抑制剂药物的用途
JP4629822B2 (ja) * 1999-12-02 2011-02-09 長瀬産業株式会社 神経成長因子合成促進剤
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1940389A2 (en) * 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
CA2676353A1 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
EP2060192B9 (en) * 2007-10-17 2016-05-04 Rudolf Wild GmbH & Co. KG Composition comprising lemon balm extracts
EP2440212A4 (en) * 2009-06-12 2013-03-20 Generex Pharm Inc COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY DISEASE
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Ｉｌ−８及びｇｍ−ｃｓｆ発現抑制剤
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Also Published As

Publication number Publication date
EP2882443A4 (en) 2016-01-06
JP2015524484A (ja) 2015-08-24
JP2023027232A (ja) 2023-03-01
EP2882443A1 (en) 2015-06-17
BR112015002739A2 (pt) 2017-07-04
AU2013299491B2 (en) 2018-03-15
AU2013299491A1 (en) 2015-02-12
JP2025029029A (ja) 2025-03-05
KR101947352B1 (ko) 2019-02-12
US20250009703A1 (en) 2025-01-09
KR20150041654A (ko) 2015-04-16
US20140044813A1 (en) 2014-02-13
CA2880708A1 (en) 2014-02-13
JP2021066735A (ja) 2021-04-30
ES2715005T3 (es) 2019-05-31
WO2014026081A1 (en) 2014-02-13
CN111358832A (zh) 2020-07-03
CA2880708C (en) 2023-09-26
CN104684562A (zh) 2015-06-03
EP2882443B1 (en) 2019-01-16

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamers and uses thereof
PL2882443T3 (pl) Wyciągi roślinne wpływające na poprawę zdrowia poznawczego i funkcji poznawczej
BR112015003354A8 (pt) métodos e composições de microcápsula
BR112015003227A2 (pt) processos de clicoconjugação e composições
EP4005507C0 (en) IMPLANT AND GUIDE
DK2928496T3 (da) Crispr-baseret genommodifikation og -regulering
EP2800590C0 (en) SLOTTED AND SIDE-OPENING CATHETER DEVICES
EP2874616A4 (en) TOPICAL DISINFECTION FORMULATIONS AND USES THEREOF
BR112014031820A2 (pt) aduto de politioéter e composição
CO6801776A2 (es) Cosmético
EP2870505A4 (en) TRANSPARENT GLOSS AND GLOSS PROTECTION STRUCTURES
EP2805637A4 (en) Foam sole, and shoes
CL2014002051A1 (es) Composiciones plaguicidas y procesos relacionados con dichas composiones
EP3039131C0 (en) ENZYME COMPOSITION AND USES
EP4066849C0 (en) DAPTOMYCIN FORMULATIONS AND THEIR USES
ZA201506496B (en) Plant regulatory elements and uses thereof
BR112014020547A2 (pt) composições oleosas e métodos de produção
ZA201506453B (en) Plant regulatory elements and uses thereof
EP2828005A4 (en) A flow restrictor
HUE036594T2 (hu) Növényi kivonatokat tartalmazó új kiszerelések
FI20125048L (fi) Voimala ja voimalan osat
BR112015007217A2 (pt) compostos e usos do composto
DK2943460T3 (da) 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf
EP2944375A4 (en) METHOD FOR PRODUCING A MICRO-CAPSULE AND MICRO-CAPSULE
EP2866794A4 (en) PLANT PARTS AND EXTRACTS WITH ANTICOCIDAL ACTIVITY